Swiss pharmaceutical giant Novartis announced plans to launch a joint venture with Google to develop a high-tech contact lens that will monitor the glucose levels of diabetic patients that wear the technology.

According to reports, Novartis’s Alcon eye care unit will join secretive research lab Google X to develop the lens. …read more

Source: Global Competition Law Blogs